Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 41 citing articles:

History repeating: guidelines to address common problems in psychedelic science
Michiel van Elk, Eiko I. Fried
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 51
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0300501-e0300501
Open Access | Times Cited: 22
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 15
MDMA and MDMA-Assisted Therapy
Aaron Wolfgang, Gregory A. Fonzo, Joshua C. Gray, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 79-103
Closed Access | Times Cited: 3
Lower-dose psycholytic therapy – A neglected approach
Torsten Passie, Jeffrey Guss, Rainer Krähenmann
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 44
History repeating: A roadmap to address common problems in psychedelic science
Michiel van Elk, Eiko I. Fried
(2023)
Open Access | Times Cited: 23
Psychedelics-assisted psychotherapy
Helena D. Aicher, Yasmin Schmid, Peter Gasser
Deleted Journal (2024) Vol. 69, Iss. 2, pp. 98-106
Open Access | Times Cited: 8
Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration
Aaron Wolfgang, Vetisha L. McClair, Paula P. Schnurr, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 17-20
Closed Access | Times Cited: 1
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
Abigail E. Calder, Seline Mock, Nicole Friedli, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 1-14
Open Access | Times Cited: 19
Psychedelic Therapy as Form of Life
Nicolas Langlitz, Alex K. Gearin
Neuroethics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis
Julia Colcott, Alexandre Guerin, Olivia Carter, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 8, pp. 1208-1226
Open Access | Times Cited: 7
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 660-678
Open Access | Times Cited: 15
Cosmology of belonging: The role of community in the therapeutic use of psychedelics
Caroline Dorsen, Lola Noero, Michelle Knapp, et al.
Palliative & Supportive Care (2025) Vol. 23
Closed Access
The neuroscientific basis of post-traumatic stress disorder (PTSD): From brain to treatment
Lila Agbaria, Foad Mirzaei, Nathalie Omar A’amar, et al.
Progress in brain research (2025)
Closed Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
Samuli Kangaslampi, Josjan Zijlmans
European Child & Adolescent Psychiatry (2023)
Open Access | Times Cited: 9
Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”
Kurt Stocker, Matthias E. Liechti
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 685-689
Open Access | Times Cited: 3
When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research
Edward Jacobs, Ashleigh Murphy-Beiner, Ian Rouiller, et al.
Neuroethics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Therapeutic frameworks in integration sessions in substance‐assisted psychotherapy: A systematised review
Sascha Thal, Paris Baker, Jonathon Marinis, et al.
Clinical Psychology & Psychotherapy (2023) Vol. 31, Iss. 1
Open Access | Times Cited: 8
Weiterbildung in Psychedelika-assistierter Therapie – Erfahrungen aus der Schweiz
Helena D. Aicher, Peter Gasser
Deleted Journal (2024) Vol. 69, Iss. 2, pp. 107-114
Open Access | Times Cited: 2
Psychedelika in der Psychiatrie
Uwe Herwig
Nervenheilkunde (2024) Vol. 43, Iss. 05, pp. 236-241
Closed Access | Times Cited: 2
Social identity processes as a vehicle for therapeutic success in psychedelic treatment
Martha Newson, S. Alexander Haslam, Catherine Haslam, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1010-1017
Closed Access | Times Cited: 2
Psychedelics and the treatment of eating disorders: considerations for future research and practice
Émilie Lacroix, Karsten Fatur, Phillipa Hay, et al.
Journal of Eating Disorders (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Self-treatment of psychosis and complex post-traumatic stress disorder with LSD and DMT—A retrospective case study
Mika Turkia
Psychiatry Research Case Reports (2022) Vol. 1, Iss. 2, pp. 100029-100029
Open Access | Times Cited: 11
Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review
Lakshan N Fonseka, Benjamin K.P. Woo
World Journal of Psychiatry (2023) Vol. 13, Iss. 5, pp. 182-190
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top